Janux Therapeutics: Barclays raises target price to $15 from $14
JANX•Barclays raised its target price for Janux Therapeutics to $15 from $14.
Related News
Fortis cuts to equal-weight from overweight; target price raised to $61 from $56
FTS•
Nasdaq trade halt continues; reason not available at 03:58 am
HCHL•
Global equity funds post seventh straight week of inflows
SPY•
Certara: Barclays raises target price to $12 from $9
CERT•
The Carlyle Group: Barclays cuts target price to $48 from $53
CG•